Ashford Capital Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-16,008
| Closed | -$837K | – | 114 |
|
|
2026
Q1 | $837K | Sell |
16,008
-21,897
| -58% | -$1.31M | 0.1% | 75 |
|
|
2025
Q4 | $2.23M | Hold |
37,905
| – | – | 0.25% | 67 |
|
|
2025
Q3 | $2.11M | Buy |
37,905
+18,937
| +100% | +$1.01M | 0.23% | 68 |
|
|
2025
Q2 | $976K | Sell |
18,968
-2,690
| -12% | -$135K | 0.11% | 76 |
|
|
2025
Q1 | $1.27M | Buy |
21,658
+698
| +3% | +$47.3K | 0.16% | 72 |
|
|
2024
Q4 | $1.51M | Hold |
20,960
| – | – | 0.18% | 66 |
|
|
2024
Q3 | $1.68M | Sell |
20,960
-2,270
| -10% | -$171K | 0.21% | 67 |
|
|
2024
Q2 | $1.66M | Hold |
23,230
| – | – | 0.22% | 65 |
|
|
2024
Q1 | $1.64M | Buy |
23,230
+5,070
| +28% | +$363K | 0.22% | 63 |
|
|
2023
Q4 | $1.4M | Hold |
18,160
| – | – | 0.19% | 69 |
|
|
2023
Q3 | $1.24M | Buy |
18,160
+6,300
| +53% | +$498K | 0.18% | 64 |
|
|
2023
Q2 | $968K | Sell |
11,860
-262
| -2% | -$21.1K | 0.14% | 66 |
|
|
2023
Q1 | $899K | Buy |
12,122
+2,170
| +22% | +$167K | 0.13% | 62 |
|
|
2022
Q4 | $825K | Sell |
9,952
-328
| -3% | -$26K | 0.13% | 63 |
|
|
2022
Q3 | $730K | Sell |
10,280
-4,592
| -31% | -$397K | 0.11% | 71 |
|
|
2022
Q2 | $1.29M | Sell |
14,872
-12
| -0.1% | -$1.13K | 0.18% | 63 |
|
|
2022
Q1 | $1.61M | Buy |
14,884
+988
| +7% | +$102K | 0.17% | 68 |
|
|
2021
Q4 | $1.8M | Buy |
13,896
+3,064
| +28% | +$376K | 0.18% | 67 |
|
|
2021
Q3 | $1.31M | Buy |
10,832
+1,788
| +20% | +$218K | 0.12% | 69 |
|
|
2021
Q2 | $1.02M | Buy |
9,044
+2,400
| +36% | +$253K | 0.09% | 80 |
|
|
2021
Q1 | $634K | Sell |
6,644
-2,120
| -24% | -$193K | 0.06% | 84 |
|
|
2020
Q4 | $696K | Buy |
8,764
+240
| +3% | +$17.4K | 0.07% | 82 |
|
|
2020
Q3 | $528K | Buy |
8,524
+5,224
| +158% | +$340K | 0.06% | 79 |
|
|
2020
Q2 | $218K | Buy |
+3,300
| New | +$198K | 0.03% | 95 |
|
|
2016
Q1 | – | Sell |
-31,052
| Closed | -$699K | – | 108 |
|
|
2015
Q4 | $699K | Sell |
31,052
-4,000
| -11% | -$91.2K | 0.16% | 74 |
|
|
2015
Q3 | $810K | Buy |
35,052
+252
| +0.7% | +$6.32K | 0.19% | 73 |
|
|
2015
Q2 | $857K | Hold |
34,800
| – | – | 0.19% | 74 |
|
|
2015
Q1 | $873K | Hold |
34,800
| – | – | 0.18% | 88 |
|
|
2014
Q4 | $804K | Buy |
+34,800
| New | +$796K | 0.16% | 90 |
|
Other funds holding TECH
HI
Ashford Capital Management's TECH Position: Q2 2026 in Review
Ashford Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 16,008 shares — an estimated $837K sold.
Ashford Capital Management first reported a position in TECH in Q4 2014 and held it in 29 quarters. The position peaked at $2.23M in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Ashford Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
- Ashford Capital Management sold 16,008 Bio-Techne shares in Q2 2026, an estimated $837K.
- Ashford Capital Management first reported a position in Bio-Techne in Q4 2014 and held it in 29 quarters.
- Ashford Capital Management's Bio-Techne position peaked at $2.23M in Q4 2025.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Ashford Capital Management's 13F filing for Q2 2026, filed 21 Aug 2026.